@article {10167,
	title = {Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study.},
	journal = {Biomarkers},
	volume = {19},
	year = {2014},
	month = {2014 Dec},
	pages = {660-6},
	abstract = {CONTEXT: A proteomic analysis has proposed fetuin-A (alpha-2-HS-glycoprotein) as a new potential marker for pancreatic cancer (PC).

OBJECTIVE: Circulating fetuin-A levels in patients with PC.

METHODS: Serum fetuin-A was measured in 81 cases with PC and 81 matched controls before the initiation of any treatment.

RESULTS: Serum fetuin-A was not independently associated with the presence of PC. Although there was a trend with higher fetuin-A levels across PC stages, comparisons of fetuin-A in patients within different PC prognostic stages revealed no differences.

CONCLUSIONS: Circulating fetuin-A was similar between patients and controls and was not associated with the disease severity.},
	keywords = {Aged, alpha-2-HS-Glycoprotein, Biomarkers, Tumor, Case-Control Studies, Female, Hospitals, Humans, Male, Middle Aged, Pancreatic Neoplasms},
	issn = {1366-5804},
	doi = {10.3109/1354750X.2014.974071},
	author = {Dalamaga, Maria and Polyzos, Stergios A and Karmaniolas, Konstantinos and Chamberland, John and Lekka, Antigoni and Migdalis, Ilias and Papadavid, Evangelia and Dionyssiou-Asteriou, Amalia and Mantzoros, Christos S}
}
